Publication:
The impact of clinical pharmacist-led hypertension screening at the community pharmacy in Türkiye

dc.contributor.authorOKUYAN, BETÜL
dc.contributor.authorSANCAR, MESUT
dc.contributor.authorsDemircioglu Akyilmaz C. E. , OKUYAN B., SANCAR M.
dc.date.accessioned2022-12-26T17:47:22Z
dc.date.available2022-12-26T17:47:22Z
dc.date.issued2022-01-01
dc.description.abstract© 2022 Marmara University Press.The aim of this study was to evaluate the impact of clinical pharmacist-led hypertension screening program (including referring high-risk individuals who are not aware of being hypertensive or prehypertensive to the physician) at a community pharmacy in Türkiye. This prospective observational pilot study was conducted in a community pharmacy located in Mersin-Türkiye between October 2017 and April 2018. Blood pressure measurements were performed by the clinical pharmacist at baseline and follow-up. The rate of participants who had high blood pressure measurements (≥140 mmHg for systolic and/or ≥90 mmHg for diastolic) was determined at the baseline by clinical pharmacist. According to the guidelines, participants with high blood pressure were referred directly to the physician by the clinical pharmacist. In the follow-up, the number of patients diagnosed with prehypertension or hypertension and the changes in their measurement of blood pressure were identified between baseline and follow-up. According to findings of clinical pharmacist-led blood pressure measurement, 23 (37.1%) out of 62 participants with high blood pressure were referred to the physician by the clinical pharmacist. In the follow-up, it was determined that 12 patients (52.2%) out of 23 participants were diagnosed with hypertension by a physician and eight patients (34.8%) out of 23 participants had prehypertensive. According to the findings of this pilot study, it was determined a positive impact of the clinical pharmacist-led hypertension screening program for high-risk individuals for hypertension.
dc.identifier.citationDemircioglu Akyilmaz C. E. , OKUYAN B., SANCAR M., "The impact of clinical pharmacist-led hypertension screening at the community pharmacy in Türkiye", Journal of Research in Pharmacy, cilt.26, sa.6, ss.1900-1906, 2022
dc.identifier.doi10.29228/jrp.280
dc.identifier.endpage1906
dc.identifier.issn2630-6344
dc.identifier.issue6
dc.identifier.startpage1900
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85142160163&origin=inward
dc.identifier.urihttps://hdl.handle.net/11424/284127
dc.identifier.volume26
dc.language.isoeng
dc.relation.ispartofJournal of Research in Pharmacy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTemel Eczacılık Bilimleri
dc.subjectEczacılık
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTemel Bilimler
dc.subjectBasic Pharmaceutics Sciences
dc.subjectPharmacology and Therapeutics
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectNatural Sciences
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectLife Sciences (LIFE)
dc.subjectPHARMACOLOGY & TOXICOLOGY
dc.subjectPHARMACOLOGY & PHARMACY
dc.subjectGenel Farmakoloji, Toksikoloji ve Eczacılık
dc.subjectFarmakoloji (tıbbi)
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology (medical)
dc.subjectclinical pharmacist
dc.subjectcommunity pharmacy
dc.subjectHypertension
dc.subjectpreventive health
dc.subjectscreening
dc.titleThe impact of clinical pharmacist-led hypertension screening at the community pharmacy in Türkiye
dc.typearticle
dspace.entity.typePublication
local.avesis.id21061569-90d3-45f5-8374-3f60ff0a3379
local.indexed.atSCOPUS
relation.isAuthorOfPublicationf6e7969a-ea61-403f-8772-1a8478556223
relation.isAuthorOfPublication87a6fc65-406c-478f-bc6d-ffaaaf1f7b31
relation.isAuthorOfPublication.latestForDiscoveryf6e7969a-ea61-403f-8772-1a8478556223

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
890.3 KB
Format:
Adobe Portable Document Format

Collections